Hemodynamic attenuation and the nitrate-free interval: Alternative dosing strategies for transdermal nitroglycerin
- 27 December 1985
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 56 (17), I32-I37
- https://doi.org/10.1016/0002-9149(85)90706-4
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Crossover from intravenous to transdermal nitroglycerin therapy in unstable angina pectorisThe American Journal of Cardiology, 1985
- Trainsdermal nitroglycerin in angina pectorisThe American Journal of Cardiology, 1984
- Hemodynamic and Hormonal Response to Transdermal Nitroglycerin in Normal Subjects and in Patients With Congestive Heart FailureJournal of the American College of Cardiology, 1983
- Nitrate tolerance: influence of isosorbide dinitrate on the hemodynamic and antianginal effects of nitroglycerinJournal of the American College of Cardiology, 1983
- Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.Circulation, 1983
- Therapeutic efficacy of a new transdermal system containing nitroglycerin in patients with angina pectorisEuropean Journal of Clinical Pharmacology, 1982
- Human pharmacological studies of a new transdermal system containing nitroglycerinEuropean Journal of Clinical Pharmacology, 1982
- Oral Isosorbide dinitrate in angina pectoris: Comparison of duration of action and dose-response relation during acute and sustained therapyThe American Journal of Cardiology, 1982
- Quantitative determination of trinitroglycerin in human plasma.Circulation, 1979
- Sustained Effects of Nitroglycerin Ointment in Patients with Angina PectorisCirculation, 1974